Ethacrynic Acid NDC 0832-1690

NDC codes

FDA NDC Directory

Product NDC (as listed)0832-1690Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00832-1690Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0832-1690-11	00832169011	100 TABLET in 1 BOTTLE (0832-1690-11)Marketed from Feb 19, 2020
0832-1690-30	00832169030	30 TABLET in 1 BOTTLE (0832-1690-30)Marketed from Feb 19, 2020

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ethacrynic Acid
Generic name (nonproprietary): ethacrynic acid
Active ingredients: Ethacrynic acid — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Upsher-Smith Laboratories, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212417
Marketing start: Feb 19, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Increased Diuresis at Loop of Henle (Physiologic effect)
Identifiers: Product ID 0832-1690_55f58d26-93c1-ab8a-e063-6394a90a73c1SPL ID 55f58d26-93c1-ab8a-e063-6394a90a73c1SPL set ID c0b17629-7e4a-4c9c-9577-4f7904564628RxCUI 1251903UNII M5DP350VZVUPC 0308321690307
Pharmacologic class: Loop Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400832169011 followed by a unit qualifier and the quantity

Package 00832-1690-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 6, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Ethacrynic acid tablets are indicated for treatment of edema when an agent with greater diuretic potential than those commonly employed is required. Treatment of the edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Short-term management of ascites due to malignancy, idiopathic edema, and lymphedema. Short-term management of hospitalized pediatric patients, other than infants, with congenital heart disease or the nephrotic syndrome. Intravenous ethacrynate sodium is indicated when a rapid onset of diuresis is desired, e.g., in acute pulmonary edema, or when gastrointestinal absorption is impaired…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)